Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. SC 13G Stake Amended Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13D Stake Beneficial Ownership Report
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Other events
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13D Stake Beneficial Ownership Report
  9. 4 Grant or award Director acquired 5,798,475 shares (grant or award)
  10. 4 Grant or award Director acquired 218,399 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 7,899,572 shares (grant or award)
  13. 4 Grant or award Director acquired 87,372 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Operating Officer acquired 430,749 shares (grant or award)

Page 28 of 40 · 798 filings